GO:0070101 positive regulation of chemokine-mediated signaling pathway: Signaling Amplification, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070101 describes any process that increases the rate, frequency or extent of a chemokine-mediated signaling pathway, a biological_process annotation in the Gene Ontology.
• Positive regulation of chemokine signaling controls directed cell migration, tissue infiltration and immune cell positioning in inflammation, infection and cancer.
• Key molecular amplifiers include chemokine receptors such as CCR2, CCR5, CXCR4 and CXCR5, integrins such as ITGA3/ITGB1, and signaling adaptors such as ZAP70.
• Dysregulated chemokine signaling amplification contributes to chronic lymphocytic leukemia migration, dermatomyositis, melanoma progression and impaired skin immunity.
• CRISPR knockout, point-mutation, knock-in and overexpression models allow causal testing of candidate amplifiers of chemokine-mediated signaling.
• Transcriptomic, proteomic and functional migration assays are standard methods for studying positive regulators of chemokine signaling.
Description
GO:0070101, positive regulation of chemokine-mediated signaling pathway, is a Gene Ontology biological_process term defined as any process that increases the rate, frequency or extent of a chemokine-mediated signaling pathway. Chemokine-mediated signaling is the cascade triggered when chemokines bind their G-protein-coupled receptors, leading to intracellular calcium flux, integrin activation, cytoskeletal rearrangement and directed cell migration. Positive regulation of this pathway therefore encompasses molecular events that amplify, sustain or enhance chemokine receptor signaling output rather than initiating it de novo. Understanding this term matters because chemokine signaling amplification is central to immune surveillance, inflammatory tissue infiltration and cancer cell dissemination. For example, ZAP70 expression enhances chemokine-driven chronic lymphocytic leukemia cell migration and arrest by regulating integrin valency, while PD-L1 reverse signaling in dermal dendritic cells promotes the migration required for skin immunity. In dermatomyositis, high levels of EPSTI1 enhance IFN-beta-mediated HLA-A expression and chemokine secretion in myoblasts, illustrating how positive regulators shape inflammatory muscle pathology. Researchers studying GO:0070101 aim to identify which genes and signals amplify chemokine responses, how these regulators are controlled, and how they can be targeted in disease.
positive regulation of chemokine-mediated signaling pathway At A Glance
| GO ID | GO:0070101 |
|---|---|
| GO term | positive regulation of chemokine-mediated signaling pathway |
| Ontology | biological_process |
| Synonym | positive regulation of chemokine-mediated signalling pathway |
| Major function | Increases the rate, frequency or extent of chemokine-mediated signaling, amplifying directed cell migration and immune cell recruitment |
| Biological context | Inflammation, immune surveillance, tissue infiltration, cancer cell migration and skin immunity |
| Example regulators | ZAP70, EPSTI1, PD-L1, integrin alpha3beta1, chemokine receptors |
| Disease relevance | Chronic lymphocytic leukemia, dermatomyositis, melanoma, impaired skin immunity |
| Research methods | CRISPR KO/knock-in, transcriptomics, proteomics, migration assays, co-expression network analysis |
What Is GO:0070101?
In plain terms, GO:0070101 is the GO annotation for any biological process that makes a chemokine-mediated signaling pathway faster, stronger or longer-lasting. The official QuickGO definition states: Any process that increases the rate, frequency or extent of a chemokine-mediated signaling pathway. It is a biological_process term, and its synonym is positive regulation of chemokine-mediated signalling pathway. This term does not describe the chemokine pathway itself but the regulatory inputs that positively modulate it, such as enhanced receptor expression, adaptor protein activity, integrin activation or sustained downstream signaling.
Why Is positive regulation of chemokine-mediated signaling pathway Important in Cell Biology?
Positive regulation of chemokine-mediated signaling is important because it determines how efficiently immune cells and pathological cells migrate toward chemokine gradients. Small changes in the expression or activity of positive regulators can dramatically alter tissue infiltration by neutrophils, lymphocytes and dendritic cells, thereby shaping inflammation, host defense and tumor progression. Because this process is amenable to genetic perturbation, it is a tractable target for mechanistic studies and therapeutic hypothesis testing.
• Controls the magnitude of immune cell recruitment during inflammation and infection.
• Regulates neutrophil tissue infiltration through integrin alpha3beta1 and other factors.
• Enhances chemokine-driven chronic lymphocytic leukemia cell migration and arrest via ZAP70.
• Promotes dendritic cell migration required for skin immunity through PD-L1 reverse signaling.
• Contributes to inflammatory myopathy through EPSTI1-enhanced chemokine secretion in dermatomyositis.
• Is implicated in melanoma tumorigenesis through co-expressed gene networks.
• Can be profiled in injured tissues by high-throughput sequencing of mRNAs and miRNAs.
• Is modulated in osteoclasts following interleukin-23 stimulation.
• Shapes antibody and transcription landscapes in elderly adults after COVID-19 booster vaccination.
• Provides CRISPR-tractable targets for validating causal amplifiers of chemokine signaling.
What Happens During positive regulation of chemokine-mediated signaling pathway?
Enhanced chemokine receptor availability and sensitivity
In simple terms: More receptors or more sensitive receptors make cells respond more strongly to chemokines.
Positive regulation can begin with increased expression or functional enhancement of chemokine receptors on the cell surface. In chronic lymphocytic leukemia, ZAP70 expression enhances chemokine-driven migration and arrest by regulating integrin valency, effectively boosting the cell response to chemokine gradients. In dermatomyositis, high EPSTI1 levels enhance IFN-beta-mediated chemokine secretion in myoblasts, increasing the chemokine signal available to surrounding cells.
Amplification of intracellular signaling adaptors
In simple terms: Inside the cell, adaptor proteins can turn up the volume of the chemokine signal.
Intracellular adaptors and kinases such as ZAP70 can amplify downstream signaling after chemokine receptor engagement. ZAP70 expression in chronic lymphocytic leukemia cells enhances chemokine-driven migration and arrest, demonstrating that adaptor-level regulation is a key node in positive regulation of chemokine-mediated signaling. This amplification can convert a modest chemokine gradient into a robust migratory response.
Integrin activation and valency regulation
In simple terms: Integrins are sticky feet that help cells grab tissue and move; their activation is part of the amplified response.
Positive regulation of chemokine signaling frequently converges on integrin activation. Integrin alpha3beta1 and other factors regulate tissue infiltration by neutrophils, linking chemokine signals to physical movement through tissues. ZAP70 enhances chemokine-driven arrest by valency regulation of integrins, showing that integrin modulation is a functional output of positive regulation.
Cytoskeletal rearrangement and directed migration
In simple terms: The cell reshapes its skeleton to move toward the chemokine.
Amplified chemokine signaling drives cytoskeletal rearrangement and directed migration. PD-L1 reverse signaling in dermal dendritic cells promotes dendritic cell migration required for skin immunity, illustrating how positive regulation translates into movement. Similarly, enhanced chemokine signaling in chronic lymphocytic leukemia promotes migration and tissue arrest.
Feedback and inflammatory amplification loops
In simple terms: Once started, the response can feed back to make more chemokines and more responsive cells.
Positive regulation can involve feedback loops that sustain chemokine production and responsiveness. EPSTI1-enhanced chemokine secretion in myoblasts in dermatomyositis suggests a local amplification loop in inflamed muscle. In osteoclasts stimulated with interleukin-23, expression profiling reveals coordinated changes that may support chemokine-mediated signaling amplification.
Key Genes Involved in GO:0070101 positive regulation of chemokine-mediated signaling pathway
The following genes and proteins have been experimentally linked to positive regulation of chemokine-mediated signaling or its functional outputs in the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ZAP70 | Enhances chemokine-driven migration and arrest by integrin valency regulation | Causal amplifier in chronic lymphocytic leukemia migration |
| EPSTI1 | Enhances IFN-beta-mediated HLA-A expression and chemokine secretion in myoblasts | Inflammatory myopathy and chemokine amplification |
| PD-L1 (CD274) | Reverse signaling promotes dendritic cell migration for skin immunity | Immune regulation and dendritic cell migration |
| ITGA3 | Integrin alpha3 subunit regulating tissue infiltration by neutrophils | Neutrophil infiltration and integrin-dependent migration |
| ITGB1 | Integrin beta1 subunit partnering with alpha3 in tissue infiltration | Integrin-mediated chemokine response |
| CCR2 | Chemokine receptor mediating monocyte migration | Chemokine receptor signaling context |
| CCR5 | Chemokine receptor involved in leukocyte recruitment | Inflammatory cell migration |
| CXCR4 | Chemokine receptor controlling homing and migration | Leukemia cell migration and arrest |
| CXCR5 | Chemokine receptor guiding B cell positioning | Lymphocyte migration studies |
| IL23 | Cytokine stimulating osteoclast expression changes | Osteoclast chemokine-related profiling |
| HLA-A | Enhanced by EPSTI1 in myoblasts | Dermatomyositis immune activation |
| IFNB1 | IFN-beta signaling upstream of chemokine secretion | Inflammatory chemokine induction |
| CD4 | T cell marker in immune profiling | Vaccination immune landscape |
| CD8A | T cell marker in immune profiling | Vaccination immune landscape |
| PTPRC | Leukocyte common antigen in immune profiling | PBMC transcription landscape |
| ACTB | Housekeeping control in expression studies | Reference gene in high-throughput sequencing |
| GAPDH | Housekeeping control in expression studies | Reference gene in expression profiling |
| B2M | Antigen presentation component in immune profiling | PBMC transcription landscape |
How Is positive regulation of chemokine-mediated signaling pathway Regulated?
Positive regulation of chemokine-mediated signaling is itself regulated at multiple levels. Receptor availability and sensitivity can be modulated by cytokines such as IFN-beta, which enhances chemokine secretion when EPSTI1 levels are high in myoblasts. Adaptor proteins such as ZAP70 can amplify downstream signaling and integrin valency, effectively increasing the rate and extent of chemokine responses. Integrin activation, including alpha3beta1, provides an additional regulatory layer that couples chemokine signals to tissue infiltration. Immune checkpoint molecules such as PD-L1 can also influence migration through reverse signaling in dendritic cells. Together, these layers allow cells to tune the strength and duration of chemokine-mediated signaling in inflammation, immunity and cancer.
positive regulation of chemokine-mediated signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ZAP70 | Chronic lymphocytic leukemia migration and arrest | CRISPR knockout in CLL cell lines followed by migration assays |
| EPSTI1 | Dermatomyositis inflammatory myopathy | Overexpression and knockout in myoblast cultures |
| PD-L1 (CD274) | Skin immunity and dendritic cell migration | Conditional knockout in mouse dendritic cells |
| ITGA3/ITGB1 | Neutrophil tissue infiltration | Integrin knockout or point-mutation in neutrophil-like cells |
| Melanoma co-expression genes | Melanoma tumorigenesis | CRISPR library screening in melanoma cell lines |
Chronic lymphocytic leukemia
In chronic lymphocytic leukemia, ZAP70 expression enhances chemokine-driven cell migration and arrest by valency regulation of integrins, directly linking positive regulation of chemokine-mediated signaling to leukemia cell trafficking and tissue retention. This makes ZAP70 and its downstream integrin targets attractive for mechanistic studies and therapeutic hypothesis testing.
Dermatomyositis and inflammatory myopathy
High levels of EPSTI1 enhance IFN-beta-mediated HLA-A expression and chemokine secretion in myoblasts in dermatomyositis, suggesting that positive regulation of chemokine signaling contributes to inflammatory muscle injury. This pathway may amplify local immune activation and chemokine gradients in affected muscle tissue.
Melanoma and tumorigenesis
Co-expression network analysis has identified genes potentially associated with melanoma tumorigenesis, including chemokine-related signaling components that may support tumor cell migration and immune interactions. Positive regulation of chemokine signaling could contribute to the inflammatory microenvironment that shapes melanoma progression.
Skin immunity and dendritic cell migration
PD-L1 reverse signaling in dermal dendritic cells promotes dendritic cell migration required for skin immunity, demonstrating that positive regulation of chemokine-mediated signaling is essential for protective immune responses in the skin. Disruption of this regulation could impair immune surveillance and response to infection.
From positive regulation of chemokine-mediated signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is ZAP70 required for chemokine-driven migration? | ZAP70 knockout in CLL cell lines |
| Does EPSTI1 amplify chemokine secretion? | EPSTI1 overexpression and knockout in myoblasts |
| Does PD-L1 reverse signaling control dendritic cell migration? | PD-L1 conditional knockout in mouse dendritic cells |
| Which integrins mediate neutrophil infiltration? | ITGA3/ITGB1 knockout or point-mutation in neutrophil-like cells |
| Which genes amplify chemokine signaling in melanoma? | CRISPR library screening in melanoma cells |
| How does IL-23 alter osteoclast chemokine-related expression? | IL-23-stimulated osteoclast cultures with transcriptomics |
How to Study the positive regulation of chemokine-mediated signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global mRNA expression changes | Identifying chemokine signaling regulators in injured tissues |
| miRNA-seq | miRNA expression changes | Discovering post-transcriptional regulators |
| Co-expression network analysis | Gene-gene co-expression modules | Melanoma tumorigenesis gene discovery |
| Migration assay | Directed cell movement toward chemokine | Testing ZAP70 and PD-L1 effects on migration |
| Integrin valency assay | Integrin activation and clustering | Linking chemokine signaling to arrest |
| PBMC transcriptomics | Immune gene expression landscape | Vaccination and immune profiling |
| Osteoclast expression profiling | Gene expression after IL-23 stimulation | Bone and inflammation studies |
| Myoblast expression profiling | Chemokine and HLA expression | Dermatomyositis mechanism studies |
Transcriptomic profiling of chemokine signaling regulators
High-throughput sequencing of mRNAs and miRNAs in injured tissues can identify positive regulators of chemokine-mediated signaling by comparing expression changes across conditions. Co-expression network analysis has been used to identify genes potentially associated with melanoma tumorigenesis, including chemokine-related components. PBMC transcription landscapes after COVID-19 booster vaccination also reveal immune gene modules relevant to chemokine responses.
Functional migration and arrest assays
Chemokine-driven migration and arrest assays are used to measure the functional output of positive regulation. ZAP70 expression enhances chemokine-driven chronic lymphocytic leukemia cell migration and arrest, and such assays can be adapted to test candidate regulators. Dendritic cell migration assays have been used to show that PD-L1 reverse signaling promotes migration required for skin immunity.
Integrin activation and valency measurements
Integrin activation states and valency can be measured to assess how positive regulators couple chemokine signaling to adhesion. Integrin alpha3beta1 and other factors regulate tissue infiltration by neutrophils, and ZAP70 enhances chemokine-driven arrest by valency regulation of integrins. These measurements link molecular regulation to physical cell behavior.
Expression profiling in disease models
Expression profiling in disease-relevant models, such as IL-23-stimulated osteoclasts or dermatomyositis myoblasts, can reveal how positive regulators of chemokine signaling are induced. Combining transcriptomics with functional assays helps distinguish correlation from causation.
How CRISPR Can Be Used to Study GO:0070101 positive regulation of chemokine-mediated signaling pathway
Knockout
CRISPR knockout of candidate positive regulators such as ZAP70, EPSTI1 or integrin subunits can test whether they are required for chemokine-driven migration and arrest. Knockout in leukemia or myoblast cell lines followed by migration assays provides causal evidence.
Point Mutation
Point mutations can be introduced to dissect specific residues required for signaling amplification, such as integrin activation sites or kinase domains. These models help distinguish structural requirements from expression-level effects.
Knock-in
Knock-in of tagged or reporter alleles allows tracking of positive regulator localization and dynamics during chemokine signaling. Tagged knock-in of ZAP70 or PD-L1 can reveal where and when amplification occurs.
Overexpression
Overexpression of candidates such as EPSTI1 or ZAP70 can test sufficiency for enhancing chemokine-mediated signaling. Overexpression in myoblasts or leukemia cells followed by chemokine secretion or migration assays provides gain-of-function evidence.
How EDITGENE Supports positive regulation of chemokine-mediated signaling pathway Research
Researchers studying positive regulation of chemokine-mediated signaling pathway-related genes often need to determine whether a candidate gene is causally involved in amplifying chemokine responses or is merely correlated with them. CRISPR-based models provide the cleanest way to establish causality, and EDITGENE offers end-to-end services to generate and validate such models.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of chemokine-mediated signaling pathway research.
Frequently Asked Questions About positive regulation of chemokine-mediated signaling pathway
What is GO:0070101 positive regulation of chemokine-mediated signaling pathway?
GO:0070101 is a Gene Ontology biological_process term defined as any process that increases the rate, frequency or extent of a chemokine-mediated signaling pathway.
What genes are involved in positive regulation of chemokine-mediated signaling?
Genes experimentally linked to this process include ZAP70, EPSTI1, PD-L1, ITGA3, ITGB1 and various chemokine receptors such as CCR2, CCR5 and CXCR4.
How does ZAP70 regulate chemokine signaling?
ZAP70 expression enhances chemokine-driven chronic lymphocytic leukemia cell migration and arrest by valency regulation of integrins.
What is the role of EPSTI1 in chemokine signaling?
High levels of EPSTI1 enhance IFN-beta-mediated HLA-A expression and chemokine secretion in myoblasts in dermatomyositis.
How is positive regulation of chemokine signaling studied?
Common methods include RNA-seq, miRNA-seq, co-expression network analysis, migration assays, integrin valency assays and CRISPR-based perturbation.
Which diseases involve positive regulation of chemokine-mediated signaling?
Chronic lymphocytic leukemia, dermatomyositis, melanoma and impaired skin immunity have been linked to altered chemokine signaling amplification.
Can CRISPR knockout be used to study chemokine signaling regulators?
Yes, CRISPR knockout of candidates such as ZAP70, EPSTI1 or integrin subunits can test their requirement in chemokine-driven migration and arrest.
What is the difference between chemokine-mediated signaling and its positive regulation?
Chemokine-mediated signaling is the core pathway triggered by chemokines, while positive regulation refers to processes that increase its rate, frequency or extent.
What cell models are suitable for studying GO:0070101?
Leukemia cell lines, myoblasts, dendritic cells, neutrophil-like cells and melanoma cells have been used in relevant studies.
How does PD-L1 relate to chemokine-mediated signaling?
PD-L1 reverse signaling in dermal dendritic cells promotes dendritic cell migration required for skin immunity, linking it to positive regulation of chemokine signaling.
Conclusion
GO:0070101 positive regulation of chemokine-mediated signaling pathway captures the regulatory inputs that amplify chemokine responses, shaping immune cell migration, tissue infiltration and disease progression. Key regulators such as ZAP70, EPSTI1, PD-L1 and integrins provide tractable entry points for mechanistic and therapeutic studies. CRISPR-based knockout, point-mutation, knock-in and overexpression models, combined with transcriptomic and functional assays, offer a rigorous path to establish causality in this pathway.
References
- 1. Li X et al.. 2025. High levels of EPSTI1 enhance IFN-β-mediated HLA-A expression and chemokine secretion in myoblasts in dermatomyositis.. Rheumatology (Oxford) 64(10):5529-5538 PMID: 40459882
- 2. Subramanian P et al.. 2016. Regulation of tissue infiltration by neutrophils: role of integrin α3β1 and other factors.. Curr Opin Hematol 23(1):36-43 PMID: 26554893
- 3. Lin H et al.. 2022. Exploring Relevant mRNAs and miRNAs in Injured Urethral Tissues of Rats with High-Throughput Sequencing.. Genes (Basel) 13(5) PMID: 35627209
- 4. Laufer JM et al.. 2018. ZAP70 expression enhances chemokine-driven chronic lymphocytic leukemia cell migration and arrest by valency regulation of integrins.. FASEB J 32(9):4824-4835 PMID: 29589978
- 5. Chen M et al.. 2020. Expression Profile of Osteoclasts Following the Stimulation With Interleukin-23 in Mice.. Arch Rheumatol 35(4):533-544 PMID: 33758810
- 6. Xuan X et al.. 2021. Identification of Genes Potentially Associated with Melanoma Tumorigenesis Through Co-Expression Network Analysis.. Int J Gen Med 14:8495-8508 PMID: 34824546
- 7. Lucas ED et al.. 2020. PD-L1 Reverse Signaling in Dermal Dendritic Cells Promotes Dendritic Cell Migration Required for Skin Immunity.. Cell Rep 33(2):108258 PMID: 33053342
- 8. Zhang Y et al.. 2024. Antibody and transcription landscape in peripheral blood mononuclear cells of elderly adults over 70 years of age with third dose of COVID-19 BBIBP-CorV and ZF2001 booster vaccine.. Immun Ageing 21(1):11 PMID: 38280989
